Literature DB >> 23178845

[The use of Surgisis® optimizes and simplifies partial nephrectomy for large renal tumors].

T J Schnoeller1, R de Petriconi, R Hefty, F Jentzmik, A Al Ghazal, J Steinestel, J Mueller, F Zengerling, M Schrader, A J Schrader.   

Abstract

BACKGROUND: With lower rates of postoperative renal failure, diabetes and cardiovascular disease, partial nephrectomy achieves longer overall survival and equally long tumor-specific survival. It is thus the current gold standard treatment for renal tumors and now also for those ≥ 4 cm in size. The main complications of nephron-sparing surgery, particularly for large and centrally located tumors, are postoperative parenchymal bleeding and urinary fistulas after opening the urinary collecting system (UCS).
MATERIAL AND METHODS: Between August 2003 and April 2012, 76 partial nephrectomies for tumors ≥ 4 cm in size were performed using porcine small intestinal submucosa (SIS, Surgisis®) to close the capsular, renal and in some cases, UCS defects.
RESULTS: The median tumor size was 5.0 cm (range 4.0-13.0 cm) and the intervention was performed with warm ischemia in 25 cases (32.8 %), with cold perfusion in 16 cases (21.2 %) and without ischemia in 35 cases (46.0 %). A total of 4 patients (5.5 %) developed postoperative urinary fistulas and 4 (5.5 %) required revision surgery because of significant postoperative bleeding. There were no local infections or allergic reactions to the foreign material.
CONCLUSIONS: Surgisis® enables a quick and technically uncomplicated closure of the renal defect after partial nephrectomy for tumors. It has the potential to further minimize postoperative bleeding and urinary fistulas and to facilitate the intervention to the extent that nephron-sparing surgery will gain broader acceptance even in patients with tumors ≥4 cm in size.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23178845     DOI: 10.1007/s00120-012-3050-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  23 in total

1.  Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm.

Authors:  Frank Becker; Stefan Siemer; Markus Hack; Ulrich Humke; Manfred Ziegler; Michael Stöckle
Journal:  Eur Urol       Date:  2006-03-23       Impact factor: 20.096

Review 2.  Nephron sparing surgery for renal tumors: indications, techniques and outcomes.

Authors:  R G Uzzo; A C Novick
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

3.  Porcine small intestine submucosa matrix (Surgisis) for esophageal perforation.

Authors:  Anthony Clough; Jonathon Ball; Garett S Smith; Steven Leibman
Journal:  Ann Thorac Surg       Date:  2011-02       Impact factor: 4.330

4.  A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Jean-Marie Marechal; Laurence Klotz; Eila Skinner; Thomas Keane; Ilse Claessens; Richard Sylvester
Journal:  Eur Urol       Date:  2006-11-15       Impact factor: 20.096

5.  Trends in renal tumor surgery delivery within the United States.

Authors:  Lori M Dulabon; William T Lowrance; Paul Russo; William C Huang
Journal:  Cancer       Date:  2010-05-15       Impact factor: 6.860

6.  Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors.

Authors:  Inderbir S Gill; Louis R Kavoussi; Brian R Lane; Michael L Blute; Denise Babineau; J Roberto Colombo; Igor Frank; Sompol Permpongkosol; Christopher J Weight; Jihad H Kaouk; Michael W Kattan; Andrew C Novick
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

7.  Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control.

Authors:  H Van Poppel; B Bamelis; R Oyen; L Baert
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

8.  Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.

Authors:  Vitaly Margulis; Pheroze Tamboli; Kenneth M Jacobsohn; David A Swanson; Christopher G Wood
Journal:  BJU Int       Date:  2007-12       Impact factor: 5.588

9.  Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.

Authors:  S E Lerner; C A Hawkins; M L Blute; A Grabner; P C Wollan; J T Eickholt; H Zincke
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450

10.  Renal Cell Carcinoma Update: News from the AUA, EAU, and ASCO Annual Meetings 2011.

Authors:  Andres Jan Schrader; Sandra Steffens
Journal:  ISRN Urol       Date:  2012-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.